Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Aurora Cannabis Inc (ACB) Price & Performance

Abeona Therapeutics IncTrade
Aurora Cannabis IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Aurora Cannabis Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while Aurora Cannabis Inc trades at $3.59 (market cap $223.59M). The key difference: Abeona Therapeutics Inc is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

ABEOACB
Market Cap
$421.19M$223.59M
Sector
HealthHealth
52-Week High
$7.45$6.23
52-Week Low
$4.17$2.58
Enterprise Value
$276.10M$168.09M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

Read more on ACB